Skip to content

Search

Showing results for "clinical trials"

The effect of CFTR modulators on structural lung disease in cystic fibrosis

Newly developed quantitative chest computed tomography (CT) outcomes designed specifically to assess structural abnormalities related to cystic fibrosis (CF) lung disease are now available. CFTR modulators potentially can reduce some structural lung abnormalities. We aimed to investigate the effect of CFTR modulators on structural lung disease progression using different quantitative CT analysis methods specific for people with CF (PwCF).

An exploratory study on the role of criminogenic risk factors and informant-rated everyday executive functioning in predicting the age of offending onset in young people with FASD

Fetal Alcohol Spectrum Disorder (FASD) is characterised by a range of neurodevelopmental deficits that may increase risks of justice system involvement. Improving our understanding of criminogenic risk factors and particularly the role of informant-rated executive functioning (EF) in predicting the age of offending onset in this clinical population may reduce recidivism and help inform targeted interventions.

ORIGINS Biobank Manager is inspiring women and girls

Meet Dr Nina D’Vaz, ORIGINS Biobank Manager who recently featured in The Kids Research Institute Australia's social media celebration of International Women and Girls in Science Day.

DiabHQ is coming

The innovative new data platform that will provide patients and families, clinicians and researchers with unparalleled access to diabetes-related information and resources is on its way. As the DiabHQ project enters its second year, we reflect on the progress to date and what lies ahead.

New position to help roll out schools program

A Clinical Nurse Specialist position within Perth Children’s Hospital’s Diabetes Service has been funded as part of the Federal Government’s new Type 1 Diabetes Management in School program.

Self-efficacy groups 2020

Perth Children’s Hospital’s Diabetes Service has released the dates for its self-efficacy groups for 2020.

Hybrid system gets big thumbs up from Andrew

Just a small taste of the hybrid closed loop pump was all it took for Andrew Parsons to jump at the chance to be involved in a longer at-home trial of the system.

Helpful phage links

We've compiled a number of helpful links to phage resources in Australia and beyond.